Chemours (CC) EPS (Weighted Average and Diluted) (2014 - 2026)

Chemours' EPS (Weighted Average and Diluted) history runs 13 years deep, the most recent figure standing at -$0.19 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) fell 533.33% year-over-year to -$0.19; the TTM figure through Mar 2026 stood at -$2.72 (down 4633.33% YoY), while the FY2025 annual figure was -$2.57, down 658.7% from the prior year.
• EPS (Weighted Average and Diluted) was -$0.19 for Q1 2026 at Chemours, up from -$0.31 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.52 in Q3 2022 to a low of -$2.53 in Q2 2025.
• Historically, EPS (Weighted Average and Diluted) has averaged -$0.02 across 5 years, with a median of -$0.03 in 2025.
• Biggest YoY gain for EPS (Weighted Average and Diluted) was 240.91% in 2025; the steepest drop was 748.72% in 2025.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.65 in 2022, then soared by 81.54% to -$0.12 in 2023, then surged by 33.33% to -$0.08 in 2024, then sank by 287.5% to -$0.31 in 2025, then jumped by 38.71% to -$0.19 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$0.19 (Q1 2026), -$0.31 (Q4 2025), and $0.31 (Q3 2025), per Business Quant data.